Clinical observations revealed that sera of acute myeloid leukemia (AML) patients have higher levels of microvesicles with an explicit molecular profile expressing membrane-associated TGFbeta1, MICA/MICB, and the myeloid blast markers CD34, CD33, CD117 (22). Here, CD34 is linked to acute myeloid leukemia.